- Home
- AACG vs TELA Comparison
AACG vs TELA Comparison
Compare AACG & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AACG
- TELA
- Stock Information
- Founded
- AACG 1999
- TELA 2012
- Country
- AACG China
- TELA United States
- Employees
- AACG N/A
- TELA N/A
- Industry
- AACG Other Consumer Services
- TELA Medical/Dental Instruments
- Sector
- AACG Real Estate
- TELA Health Care
- Exchange
- AACG Nasdaq
- TELA Nasdaq
- Market Cap
- AACG 51.9M
- TELA 60.6M
- IPO Year
- AACG N/A
- TELA 2019
- Fundamental
- Price
- AACG $1.31
- TELA $1.32
- Analyst Decision
- AACG
- TELA Buy
- Analyst Count
- AACG 0
- TELA 3
- Target Price
- AACG N/A
- TELA $5.33
- AVG Volume (30 Days)
- AACG 58.0K
- TELA 94.4K
- Earning Date
- AACG 11-10-2025
- TELA 11-06-2025
- Dividend Yield
- AACG N/A
- TELA N/A
- EPS Growth
- AACG N/A
- TELA N/A
- EPS
- AACG N/A
- TELA N/A
- Revenue
- AACG $39,064,701.00
- TELA $75,323,000.00
- Revenue This Year
- AACG N/A
- TELA $25.72
- Revenue Next Year
- AACG N/A
- TELA $22.03
- P/E Ratio
- AACG N/A
- TELA N/A
- Revenue Growth
- AACG 15.19
- TELA 16.34
- 52 Week Low
- AACG $0.70
- TELA $0.86
- 52 Week High
- AACG $2.58
- TELA $3.26
- Technical
- Relative Strength Index (RSI)
- AACG 43.09
- TELA 26.73
- Support Level
- AACG $1.15
- TELA $1.45
- Resistance Level
- AACG $1.38
- TELA $1.51
- Average True Range (ATR)
- AACG 0.14
- TELA 0.07
- MACD
- AACG 0.03
- TELA -0.01
- Stochastic Oscillator
- AACG 56.82
- TELA 20.00
About AACG ATA Creativity Global
ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments of the company are (i) Overseas art study services (ii) Other educational services and (iii) Other services. Majority of its revenue comes from Overseas art study services.
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.